Publication | Open Access
The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma
249
Citations
2
References
2010
Year
AsthmaGerald Dal PanComprehensive ReviewPharmacologyClinical TrialsLong-acting Beta-agonistsLaboratory MedicineTherapeutic EfficacyClinical PharmacologyEvidence-based MedicinePharmacotherapyClinical ReviewPharmacologic InterventionBadrul ChowdhuryMedicineSafe Use
The FDA has conducted a comprehensive review of the benefits and risks of using LABAs to treat asthma. Drs. Badrul Chowdhury and Gerald Dal Pan discuss the agency's conclusions.
| Year | Citations | |
|---|---|---|
Page 1
Page 1